Cited by 221Alcohol Consumption and Health EffectsHepatocellular Carcinoma Treatment and PrognosisCancer Risks and Factors

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study

Open access

Loomba, Rohit, Yang, Hwai-I, Su, Jun, Brenner, David, Barrett-Connor, Elizabeth, Iloeje, Uchenna, Chen, Chien-Jen·2013·American Journal of Epidemiology

DOI 10.1093/aje/kws252PMC PMC3626057

Open this paper in CoChat — free account

Abstract

Obesity and alcohol interact to increase the risk of death from liver failure in men. In the present study, we aimed to examine whether obesity and alcohol were multiplicative or additive in increasing the risk of hepatocellular carcinoma (HCC) in both men and women. We conducted a prospective, population-based study of 23,712 Taiwanese residents (50.3% men) from 7 townships who underwent an evaluation for liver disease and were followed for 11.6 years for incident HCC. The mean age was 47 (standard deviation, 10) years and the mean body mass index (weight (kg)/height (m)(2)) was 24 (standard deviation, 3). Overall, 305 cases of HCC were identified over 275,126 person-years of follow-up. Age, male sex, alcohol drinking, cigarette smoking, elevated alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus positivity, and diabetes mellitus were each statistically significant predictors of incident HCC in univariate analyses (P < 0.05). Alcohol use and obesity (body mass index ≥30) showed a synergistic association with the risk of incident HCC in both unadjusted analyses (hazard ratio = 7.19, 95% confidence interval: 3.69, 14.00; P < 0.01) and multivariable-adjusted analyses (age, sex, smoking, serum alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus antibody, and diabetes mellitus) (hazard ratio = 3.82, 95% confidence interval: 1.94, 7.52; P < 0.01). Relative excess risks due to interaction, attributable proportion, and synergy index were 4.83, 0.67, and 4.53, respectively, suggesting a multiplicative interaction between alcohol use and obesity. Obesity and alcohol synergistically increase the risk of incident HCC.

Integrity signals

Registry

Crossref · 10.1093/aje/kws252

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H., Lu, S., Liaw, Y., You, S., Sun, C., Wang, L., Hsiao, C. K., Chen, P., Chen, D., & Chen, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,220
Hepatocellular carcinoma: Recent trends in the United States
El‐Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 971
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El‐Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 940
CONCEPTS OF INTERACTION
ROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859 · cited 1×
“To test whether the interaction is additive or multiplicative, we examined the combined impact of alcohol and obesity on HCC risk by relative excess risk due to interaction (RERI), attributable proportion (AP), and synergy index (SI) and their respective confidence intervals, as previously described (30, 31).”
Method
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710

Show all 37 references

Research works printed but not linked: 1

World Health Organization, The Global Burden of Disease: 2004 Update

Sorted by citations

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association
Rychik, J. R., Atz, A. M., Celermajer, D. S., Deal, B. J., Gatzoulis, M. Α., Gewillig, M. H. M. L., Hsia, T., Hsu, D. T., Kovacs, A. H., McCrindle, B. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000696 · Cited by 1,055
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Kerr, J., Anderson, C. A. M., & Lippman, S. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30411-4 · Cited by 706
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Hepatitis B
Jeng, W., Papatheodoridis, G., & Lok, A. S.-F. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01468-4 · Cited by 620
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
Altekruse, S. F., Henley, S. J., Cucinelli, J. E., & McGlynn, K. A. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.11 · Cited by 429
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
Loomba, R. S., Lim, J. K., Patton, H. M., & El‐Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 360
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
Younossi, Z., & Henry, L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.005 · Cited by 334
“HCC Patients with NAFLD or ALD are at risk for developi ng HCC, which leads to death or liver transplantation [77-86].”
Background
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 336
Chemopreventive strategies in hepatocellular carcinoma
Singh, S., Singh, P. P., Roberts, L. R., & Sánchez, W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.143 · Cited by 276
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Åberg, F., Helenius‐Hietala, J., Puukka, P., Färkkilä, M., & Jula, A. (2018) · Hepatology · doi:10.1002/hep.29631 · Cited by 267
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264
Pathogenesis of Alcoholic Liver Disease
Dunn, W., & Shah, V. H. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.02.004 · Cited by 221
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Kim, W. R., Loomba, R. S., Berg, T., Schall, R. A., Yee, L. J., Dinh, P. V., Flaherty, J. F., Martins, E. B., Therneau, T. M., Jacobson, I. M., et al. (2015) · Cancer · doi:10.1002/cncr.29537 · Cited by 212
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Dhanasekaran, R., Bandoh, S., & Roberts, L. R. (2016) · F1000Research · doi:10.12688/f1000research.6946.1 · Cited by 214
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M. A., Dufour, J., Gerbes, A. L., Zoulim, F., Bataller, R. A., Burra, P., Cortez‐Pinto, H., Gao, B., Gilmore, I. T., Mathurin, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 210
Non-alcoholic fatty liver disease: What the clinician needs to know
Machado, M. V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12956 · Cited by 215
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B
Chan, A. W. H., Wong, G. L., Chan, H., TONG, J. H. M., Yu, Y., Choi, P. C. L., Chan, H. L., To, K., & Wong, V. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13536 · Cited by 204
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., & Yoon, S. K. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0176 · Cited by 177
Diet and liver cancer risk: a narrative review of epidemiological evidence
Yang, W., Zeng, X., Liu, Z., Zhao, Q.-H., Tan, Y., Gao, J., Li, H., & Xiang, Y. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001208 · Cited by 166
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Boyle, M., Masson, S., & Anstee, Q. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.006 · Cited by 162
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
Degasperi, E., & Colombo, M. (2016) · The Lancet Gastroenterology and Hepatology · doi:10.1016/s2468-1253(16)30018-8 · Cited by 144
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Desai, B. N., Singhal, G., Watanabe, M., Stevanovic, D., Lundasen, T., Fisher, F. M., Mather, M. L., Vardeh, H. G., Douris, N., Adams, A. C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.004 · Cited by 150
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration
Roh, Y. S., Zhang, B., Loomba, R. S., & Seki, E. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00031.2015 · Cited by 146
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Лазебник, Л. Б., Голованова, Е. В., Туркина, С. В., Raikhelson, K. L., Okovityy, S. V., Drapkina, O. M., Maev, I. V., Ai, M., Ройтберг, Г. Е., Khlynova, O. V., et al. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-185-1-4-52 · Cited by 165
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M., & Arab, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00448 · Cited by 136
Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
Lange, N. F., Radu, P., & Dufour, J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.025 · Cited by 144
Alcohol and hepatocellular carcinoma
Matsushita, H., & Takaki, A. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000260 · Cited by 110
“52).(66) Although the mechanisms of the synergistic effect between ALD and diabetes are unknown, several mechanisms have been suggested to underlie the development of diabetes and/or obesity-induced HCC in patients with non-alcoholic steatohepatitis.”
Background
Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma
Hassan, M. M., Abdel-Wahab, R., Kaseb, A., Shalaby, A., Phan, A. T., El-Serag, H. B., Hawk, E., Morris, J., Singh Raghav, K. P., Lee, J.-S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.044 · Cited by 110
Alcoholic Beverage Consumption and Chronic Diseases
Zhou, Y., Zheng, J., Li, S., Zhou, T., Zhang, P., & Li, H. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13060522 · Cited by 109
Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma
Loomba, R. S., Liu, J. B., Yang, H., Lee, M., Lu, S., Wang, L., Iloeje, U. H., You, S., Brenner, D. A., & Chen, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.043 · Cited by 105
The impact of obesity and metabolic syndrome on alcoholic liver disease
Chiang, D. J., & McCullough, A. J. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.006 · Cited by 99
Epidemiology of Virus Infection and Human Cancer
Chen, C., Hsu, W.-L., Yang, H., Lee, M., Chen, H.-C., Chien, Y.-C., & You, S. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_2 · Cited by 100
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 90
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Åberg, F. O., & Färkkilä, M. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1701443 · Cited by 87
Alcohol consumption and liver cancer risk: a meta-analysis
Chuang, S., Lee, Y.-C. A., Wu, G.-J., Straíf, K., & Hashibe, M. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0615-3 · Cited by 79
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
Chrysavgis, L., Giannakodimos, I., Diamantopoulou, P., & Cholongitas, Ε. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.310 · Cited by 84
Hepatocellular carcinoma and the risk of occupational exposure
Rapisarda, V., Loreto, C., Malaguarnera, M., Ardiri, A., Proiti, M., Giuseppe, R., Frazzetto, E., Ruggeri, M. I., Malaguarnera, G., Bertino, N., et al. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i13.573 · Cited by 79
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
Williams, R. L., Aithal, G. P., Alexander, G., Allison, M., Armstrong, I. J., Aspinall, R., Baker, A., Batterham, R. L., Brown, K., Burton, R., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32908-3 · Cited by 78
Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
Tomic, D., Kemp, W. W., & Roberts, S. K. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001235 · Cited by 76
Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease
Mahli, A., & Hellerbrand, C. (2016) · Digestive Diseases · doi:10.1159/000447279 · Cited by 73
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
Chang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 74
NAFLD in normal weight individuals
DiStefano, J. K., & Gerhard, G. S. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00814-z · Cited by 72
Radix Puerariae thomsonii polysaccharide (RPP) improves inflammation and lipid peroxidation in alcohol and high-fat diet mice by regulating gut microbiota
Li, Q., Liu, W., Feng, Y., Hou, H., Zhang, Z., Yu, Q., Zhou, Y., Luo, Q., Luo, Y., Ouyang, H., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.067 · Cited by 70
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Ramadori, P., Cubero, F. J., Liedtke, C., Trautwein, C., & Nevzorova, Y. A. (2017) · Cancers · doi:10.3390/cancers9100130 · Cited by 70
Alcoholic and non-alcoholic steatohepatitis
Neuman, M. G., French, S. W., French, B. A., Seitz, H. K., Cohen, L. B., Mueller, S., Osna, N. A., Kharbanda, K. K., Seth, D., Bautista, A. P., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.09.005 · Cited by 73
Combined alcoholic and non-alcoholic steatohepatitis
Wandji, L. C. N., Gnemmi, V., Mathurin, P., & Louvet, A. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100101 · Cited by 70
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study
Huang, Y., Wang, T., Yang, S., Lin, S., Fu, S., Hu, J. ‐., Liu, C., Kao, J., & Chen, D. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13341 · Cited by 69
Controversies in the Diagnosis and Management of NAFLD and NASH.
Rinella, M. E., Loomba, R. S., Caldwell, S. H., Kowdley, K. V., Charlton, M., Tetri, B. A., & Harrison, S. A. (2014) · PubMed · Cited by 66
Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies
Åberg, F., Färkkilä, M., & Männistö, V. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14271 · Cited by 63
Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection
Chen, C., Yang, Y., Lin, M., Lee, C., Tsan, Y., Lai, M., Yang, H., Ho, W., & Chen, P. (2018) · International Journal of Cancer · doi:10.1002/ijc.31544 · Cited by 61
Association between proton pump inhibitors and the risk of hepatocellular carcinoma
Shao, Y. J., Chan, T., Tsai, K. K., & Wu, S. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14835 · Cited by 60
Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study
Fu, S., Huang, Y., Wang, T., Hu, J. ‐., Chen, D., & Yang, S. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13191 · Cited by 63
Large Variations in Risk of Hepatocellular Carcinoma and Mortality in Treatment Naïve Hepatitis B Patients: Systematic Review with Meta-Analyses
Thiele, M. S., Gluud, L. L., Fialla, A. D., Dahl, E., & Krag, A. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107177 · Cited by 56
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study
Zeng, Q., Xu, G., Zhang, J., Li, W., Zhang, D., Li, Z., Liang, H., Li, C., & Yu, Z. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.025 · Cited by 52
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Thomaides-Brears, H. B., Lepe, R., Banerjee, R., & Duncker, C. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02684-3 · Cited by 49
Alcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 51
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 51
Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease
Patel, V. A., Sanyal, A. J., & Sterling, R. K. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.006 · Cited by 48
Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults
Im, P. K., Millwood, I. Y., Kartsonaki, C., Guo, Y., Chen, Y., Turnbull, I. J., Yu, C., Du, H., Pei, P., Lv, J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02079-1 · Cited by 49
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Argenziano, M. E., Kim, M. N., Montori, M., Bucchianico, A. D., Balducci, D., Ahn, S. H., & Svegliati‐Baroni, G. (2024) · Hepatology International · doi:10.1007/s12072-024-10692-4 · Cited by 52
Alcohol Use and Gastrointestinal Cancer Risk
Scherübl, H. (2020) · Visceral Medicine · doi:10.1159/000507232 · Cited by 46
Brazilian Journal of Development
(2021) · doi:10.34117/25258761 · Cited by 46
MAFLD: an optimal framework for understanding liver cancer phenotypes
Crane, H., Gofton, C., Sharma, A., & George, J. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02021-7 · Cited by 46
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
Sripongpun, P., Kaewdech, A., Udompap, P., & Kim, W. R. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101127 · Cited by 45
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Rivera‐Esteban, J., Muñoz, S., Higuera, M., Sena, E., Bermúdez-Ramos, M., Bañares, J., Martínez-Gómez, M., Cusidó, M. S., Jiménez-Masip, A., Francque, S., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.028 · Cited by 45
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
Hagström, H., Hegmar, H., & Moreno, C. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12524 · Cited by 40
Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
Leal-Lassalle, H., Estévez‐Vázquez, O., Cubero, F. J., & Nevzorova, Y. A. (2025) · npj gut and liver. · doi:10.1038/s44355-024-00014-8 · Cited by 50
Chemokine ligand 20 enhances progression of hepatocellular carcinomaviaepithelial-mesenchymal transition
Hou, K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.475 · Cited by 41
How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
Sookoian, S. C., & Pirola, C. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.002 · Cited by 41
Genetic Factors, Viral Infection, Other Factors and Liver Cancer: An Update on Current Progress
Su, C., Lin, Y., & Cai, L. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.4953 · Cited by 40
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Petroni, M. L., Brodosi, L., Marchignoli, F., Musio, A., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11123048 · Cited by 42
RETRACTED: Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma
Tang, H., Zhang, J., Yu, Z., Ye, L., Li, K., Ding, F., Feng, X., & Meng, W. (2017) · Technology in Cancer Research & Treatment · doi:10.1177/1533034617735931 · Cited by 39
Retracted
Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies
Peña, S., Mäkelä, P., Laatikainen, T. K., Härkänen, T., Männistö, S., Heliövaara, M., & Koskinen, S. V. P. (2021) · Addiction · doi:10.1111/add.15395 · Cited by 39
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
Ciaula, A. D., Bonfrate, L., Krawczyk, M. J., Frühbeck, G., & Portincasa, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052636 · Cited by 37
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
Ratziu, V., Ghabril, M., Romero‐Gómez, M., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002483 · Cited by 40
Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors
Zhang, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i12.3554 · Cited by 38
Epidemiology of Virus Infection and Human Cancer
Chen, C., You, S., Hsu, W., Yang, H., Lee, M., Chen, H., Chen, Y., Liu, J. B., Hu, H.-H., Lin, Y., et al. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_2 · Cited by 37
Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees
Yamamura, S., Kawaguchi, T., Nakano, D., Tomiyasu, Y., Yoshinaga, S., Doi, Y., Takahashi, H., Anzai, K., Eguchi, Y., Torimura, T., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13436 · Cited by 36
Sleep Deprivation and Recovery Sleep Prior to a Noxious Inflammatory Insult Influence Characteristics and Duration of Pain
Vanini, G. (2015) · SLEEP · doi:10.5665/sleep.5334 · Cited by 36
Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis
Dash, S., Aydın, Y., & Wu, T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.015 · Cited by 36
Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
Yun, B., Park, H., Ahn, S. H., Oh, J., Kim, B. K., & Yoon, J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002920 · Cited by 34
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
Hoki, T., Katsuta, E., Yan, L., Takabe, K., & Ito, F. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.008 · Cited by 36
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Zelber‐Sagi, S., Noureddin, M., & Shibolet, O. (2021) · Cancers · doi:10.3390/cancers14010103 · Cited by 33
Management of fatty liver disease with the metabolic syndrome
Machado, M. V., & Cortez‐Pinto, H. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.903798 · Cited by 31
Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity
Innes, H. A., Crooks, C. J., Aspinall, E., Card, T. R., Hamill, V., Dillon, J. F., Guha, I. N., Hayes, P. C., Hutchinson, S. J., West, J., et al. (2021) · Hepatology · doi:10.1002/hep.32123 · Cited by 31
Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors
Han, H., Hu, J., Lau, M. Y., Feng, M., Petrovic, L. M., & Ji, C. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00224 · Cited by 31
Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
Zeng, Q., Yu, Z., Shang, J., Xu, G., Sun, C.-Y., Liu, N., Li, C., Lv, J., Liu, Y., Liang, H., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa208 · Cited by 30
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice
Canivet, C. M., Boursier, J., & Loomba, R. S. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1785196 · Cited by 29
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia
Huang, Y., Joseph, J., de Boer, W. B., Cheng, W., Adams, L. A., MacQuillan, G. C., Garas, G., Raftopoulos, S., & Jeffrey, G. P. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.013 · Cited by 28
Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH
Bataller, R. A., Cabezas, J., Aller, R., Cots, M. V., Abad, J., Albillos, A., Altamirano, J., Arias, M., Bañares, R., Caballería, J., et al. (2019) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2019.09.006 · Cited by 28
Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank
Eroglu, E. I., Huang, B., Ahmadi, M. N., Johnson, N. A., El-Omar, E. M., & Stamatakis, E. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00923-4 · Cited by 28
Alcohol and its associated liver carcinogenesis
Jacob, R., Prince, D. S., Kench, C., & Liu, K. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16248 · Cited by 29
Obesity and excess weight in early adulthood and high risks of arsenic-related cancer in later life
Steinmaus, C., Castriota, F., Catterina Ferreccio, R., Smith, A. H., Yan Yuan, A., Liaw, J., Acevedo, J., Pérez, L., Meza, R., Calcagno, S., et al. (2015) · Environmental Research · doi:10.1016/j.envres.2015.07.021 · Cited by 28
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 27

Authors: Loomba, R., Yang, H.-I., Su, J., Brenner, D., Barrett-Connor, E., Iloeje, U., & Chen, C.-J.
Affiliations: University of California San Diego (US)
Corresponding author: Loomba, Rohit
ORCID: Loomba, Rohit
Yang, Hwai-I
Su, Jun
Brenner, David
Barrett-Connor, Elizabeth
Chen, Chien-Jen
Venue: American Journal of Epidemiology
Publisher: Oxford University Press (OUP)
Published: 2013-01-24
Volume: 177
Issue: 4
Pages: 333-342
ISSN: 0002-9262 (ISSN-L)
1476-6256
DOI: 10.1093/aje/kws252
PMC: PMC3626057
OpenAlex: W2116448477
Cited by: 221
References: 37
Citations by year: 2026: 8 · 2025: 14 · 2024: 17 · 2023: 21 · 2022: 18 · 2021: 23 · 2020: 17 · 2019: 20 · 2018: 11 · 2017: 12 · 2016: 17 · 2015: 20 · 2014: 13 · 2013: 9
FWCI: 14.71
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: American Journal of Epidemiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA23100-27, P30CA023100)
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK090303)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords: hepatocellular carcinoma, obesity, alcohol consumption, synergistic interaction, multiplicative interaction, body mass index, liver cancer risk factors, hepatitis B, hepatitis C, diabetes mellitus, smoking, alanine aminotransferase, Taiwanese population
MeSH terms: Adult, Alanine Transaminase, Alcohol Drinking, Algorithms, Analysis of Variance, Female, Follow-Up Studies, Hepatitis B Surface Antigens, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Obesity, Prospective Studies, Risk Factors, Smoking, Taiwan, Biomarkers, Tumor, Cohort Studies, Body Mass Index, Incidence, Multivariate Analysis, Confidence Intervals, Odds Ratio, Hepatitis C Antibodies, Hepatitis B, Chronic, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks